Navigation Links
Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstage™ GCC Colorectal Cancer Staging Test
Date:6/29/2011

ence, to determine which patients might benefit most from adjuvant chemotherapy and which could be safely managed without chemotherapy.

To date, results of published studies totaling over 1,000 patients have shown that the GCC biomarker is a better predictor, than traditionally-used factors, of disease recurrence in early-stage colorectal cancer patients.

In particular, in a recent study (Annals of Surgical Oncology, May 2011), in a sub-set of 181 stage II colon cancer patients, the Previstage™ GCC test classified one-third of patients as having a high risk of recurrence following surgery and two-thirds of patients at low risk of recurrence. The high risk group had a six times greater likelihood of recurrence than the low risk group (27% versus 4%).

About Signal Genetics

Signal Genetics, the parent company of Myeloma Health LLC, Respira Health LLC and CC Health LLC, is a privately held predictive genetic testing company focused on improving the treatment of cancer patients. The goal of Signal Genetics is to provide cancer patients and their physicians with novel and innovative insights into their disease, including predictive outcome of disease stage, odds of relapse, and the optimal treatment regimen based on their specific genetic expression profile. The Company launched its first molecular diagnostic test in December, 2010, Myeloma Prognostic Risk Signature (MyPRS™) via its CLIA laboratory in Little Rock, Arkansas. Signal Genetics has marketing partnerships with two large, national laboratories, including Caris Life Sciences and NeoGenomics Laboratories.  Additional information is available at www.signalgenetics.com.

About DiagnoCure

DiagnoCure (TSX: CUR) is a life sciences company that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, th
'/>"/>

SOURCE Signal Genetics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
2. Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area
3. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
4. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. Device Blocking Stomach Nerve Signals Shows Promise in Obesity
7. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
8. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
9. St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer
10. AGI Dermatics Clinical Data Indicate Bicyclic Monoterpene Diols Suppress MMP1 and Stimulate Collagen Through TNF-a Signaling
11. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... NORTH WALES, Pa., Aug. 18 AirPal ®, ... and positioning technology, has announced the expansion of its ... positioning functionality. "This announcement marks the launch ... Positioning™ systems," said Jim Weedling, President AirPal, Inc.  "Among ...
... LAUDERDALE, Fla., Aug. 18 After a lengthy ... of power mobility products and services, has selected ... to help strengthen and broaden the company,s brand ... Advertising and Daggerwing, Omnicom,s team will include Javelin ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2Omnicom Adds National Healthcare Giant to Client Roster 2Omnicom Adds National Healthcare Giant to Client Roster 3
(Date:5/26/2015)... 2015 Foot and Ankle Specialists ... J. Leone (Pasadena and Baltimore Divisions) was recently ... Podiatric Medical Association (MPMA) President from 2013 to 2015 ... his Doctorate in Podiatric Medicine from Temple University in ... Hospital in Voorhees, New Jersey. Dr. Leone is ...
(Date:5/26/2015)... The Brain Aneurysm Foundation is proud to announce ... Conductor Keith Lockhart will once again team up for ... 4th Annual Brain Aneurysm Foundation Night at the ... to feature an exclusive Brain Aneurysm Foundation reception with ... lost his sister-in-law to a brain aneurysm years ago. ...
(Date:5/26/2015)... Carl W. Berk, M.D. and his ... Pinehurst, N.C. have launched a Balloon Sinuplasty website to ... sinusitis and the benefits of Balloon Sinuplasty. , The ... determine if someone is a good candidate for Balloon ... factors that can contribute to chronic nasal congestion. If ...
(Date:5/25/2015)... City, NY (PRWEB) May 26, 2015 ... honors Anne King as a 2015-2016 inductee ... She is recognized with this prestigious distinction for leadership ... organization exclusively for professional women, boasting more than 700,000 ... "I’m pleased to welcome Anne into this exceptional group ...
(Date:5/25/2015)... 25, 2015 World Patent Marketing, a ... The Preventer, a home patent that aims to protect ... , "House fires cost the United States a total ... and Creative Director of World Patent Marketing . ... homes that have no alarmed protection. With the use ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Anne King, Operating Principal at Keller Williams, Into its VIP Professional Woman of the Year Circle 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3
... in hospital patients also leads to higher costs, study ... popular stomach acid reducer greatly increases the risk of ... study has found. , Researchers at Wake Forest University ... of 834 cardiothoracic surgery patients on breathing machines who ...
... , WEINER,S NEW YORK TIMES LETTER TODAY REFUTES CLAIMS OF ... The Public Option is still viable as the House is set ... nor on ,life support, (ABC News)," says Robert Weiner, former Chief of Staff ... the White House National Drug Policy Office. , , ...
... , LAKE SUCCESS, N.Y., Sept. 18 ... support the dissemination of tools and research findings aimed ... in the United States. Under the Agency for Healthcare ... receive specific task assignments to support accelerated dissemination of ...
... COPLEY, Ohio, Sept. 18 The Autism Family Foundation of ... Center for Autism this afternoon, kicking off the construction of ... Three of the center,s partners, Robert J. Keegan, ... William Considine, president of Akron Children,s Hospital, and Linda Fuline, ...
... one third of healthcare workers have themselves vaccinated against ... against influenza viruses is considered safe and effective and ... transmission of disease to patientsprovided at least 50% of ... Deutsches rzteblatt International ( Dtsch Arztebl Int ...
... PHILADELPHIA, Sept. 18 The Children,s Hospital of ... fundraising campaign with a reception to honor Children,s Hospital,s ... the unbridled growth of Children,s Hospital and the exemplary commitment ... Washington, Pennsylvania have graciously opened their home, Karamoor, to recognize ...
Cached Medicine News:Health News:Ulcer Preventative May Raise Pneumonia Risks 2Health News:Public Option Still Viable As House Set to Pass It -- Not 'Fading,' Says Robert Weiner, Former House Aging Committee Director 2Health News:IPRO Wins Knowledge Transfer/Implementation Federal Contract From AHRQ 2Health News:Groundbreaking Ceremony Held for New Autism Center 2Health News:The Children's Hospital of Philadelphia Celebrates a Successful Finish to its Hope Lives Here Fundraising Campaign 2Health News:The Children's Hospital of Philadelphia Celebrates a Successful Finish to its Hope Lives Here Fundraising Campaign 3Health News:The Children's Hospital of Philadelphia Celebrates a Successful Finish to its Hope Lives Here Fundraising Campaign 4Health News:The Children's Hospital of Philadelphia Celebrates a Successful Finish to its Hope Lives Here Fundraising Campaign 5
Sphenoidal electrodes provide a less invasive method of recording brain activity in the epilepsy patient. Like all Integra Epilepsy electrodes, sphenoidal electrodes are fabricated from implant-grade...
... in collaboration with Dr. George Ojemann ... Ojemann Cortical Stimulator is the industry ... This portable, constant current unit has ... suitable for use in the awake ...
These are superior quality electrodes, fabricated from a single length of polyurethane tubing for strength and uniform smoothness. They are furnished with a specially-designed rigid stylet to facilit...
... The patented Integra Epilepsy ... advance in the design of ... connector simplifies lead tunneling and ... cable. The Flex Connector is ...
Medicine Products: